Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin P Bliden

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Platelets|January 10, 2004
A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activityPaul A Gurbel, Kevin P Bliden
Thrombosis Research|March 12, 2004
The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapyPaul A Gurbel, Kevin P Bliden
American Heart Journal|October 18, 2003
Platelet activation after stenting with heparin-coated versus noncoated stentsPaul A Gurbel, Kevin P Bliden
The American Journal of Cardiology|April 26, 2003
Durability of platelet inhibition by clopidogrelPaul A Gurbel, Kevin P Bliden
Circulation|June 2, 2020
Can an Old Ally Defeat a New Enemy?Paul A Gurbel, Kevin P Bliden, Karsten Schrör
Circulation. Cardiovascular Interventions|April 17, 2014
Letter by Grbel et al regarding article, "administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome"Paul A Gurbel, Kevin P Bliden, Udaya S Tantry
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 7, 2005
What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?Udaya S Tantry, Kevin P Bliden, Paul A Gurbel
Expert Opinion on Pharmacotherapy|October 4, 2005
Resistance to antiplatelet drugs: current status and future researchUdaya S Tantry, Kevin P Bliden, Paul A Gurbel
Journal of the American College of Cardiology|December 13, 2006
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b studyPaul A Gurbel, Kevin P Bliden, Udaya S Tantry
Expert Opinion on Investigational Drugs|January 25, 2007
AZD6140Udaya S Tantry, Kevin P Bliden, Paul A Gurbel
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Platelets|January 10, 2004
A new method of representing drug-induced platelet inhibition: better description of time course, response variability, non-response, and heightened activityPaul A Gurbel, Kevin P Bliden
Thrombosis Research|March 12, 2004
The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapyPaul A Gurbel, Kevin P Bliden
American Heart Journal|October 18, 2003
Platelet activation after stenting with heparin-coated versus noncoated stentsPaul A Gurbel, Kevin P Bliden
The American Journal of Cardiology|April 26, 2003
Durability of platelet inhibition by clopidogrelPaul A Gurbel, Kevin P Bliden
Circulation|June 2, 2020
Can an Old Ally Defeat a New Enemy?Paul A Gurbel, Kevin P Bliden, Karsten Schrör
Circulation. Cardiovascular Interventions|April 17, 2014
Letter by Grbel et al regarding article, "administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome"Paul A Gurbel, Kevin P Bliden, Udaya S Tantry
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|October 7, 2005
What is the best measure of thrombotic risks--pretreatment platelet aggregation, clopidogrel responsiveness, or posttreatment platelet aggregation?Udaya S Tantry, Kevin P Bliden, Paul A Gurbel
Expert Opinion on Pharmacotherapy|October 4, 2005
Resistance to antiplatelet drugs: current status and future researchUdaya S Tantry, Kevin P Bliden, Paul A Gurbel
Journal of the American College of Cardiology|December 13, 2006
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b studyPaul A Gurbel, Kevin P Bliden, Udaya S Tantry
Expert Opinion on Investigational Drugs|January 25, 2007
AZD6140Udaya S Tantry, Kevin P Bliden, Paul A Gurbel
Pageof 15